ClinicalTrials.gg
RecruitingNCT07767383Updated Aug 17, 2026

Effect of Dexmedetomidine Combined With FNB/ACB on Sleep Quality After Knee Surgery

A Phase 4 interventional study of ropivacaine (local infiltration) and Dexmedetomidine in Knee Arthroscopic Surgery, sponsored by Affiliated Hospital of Nantong University. Recruiting at 1 site in China. Open to participants aged 18 Years to 85 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-17.

Sponsored by Affiliated Hospital of Nantong University · Phase 4, Interventional, and Treatment

From the registry’s dates

  • Registered 5 months after the study started (first participant enrolled Jan 2026, registered Jun 2026).
  • Started Jan 2026; still recruiting 10 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 4
Study type
Interventional
Enrollment
136
Allocation
Randomized
Ages
18 Years to 85 Years
Sex
All
01

Study summary

The goal of this randomized, double-blind, placebo-controlled, 2×2 factorial trial is to evaluate the effect of intraoperative dexmedetomidine combined with either femoral nerve block (FNB) or adductor canal block (ACB) on postoperative sleep quality in patients aged 18-85 years with ASA I-III undergoing elective knee arthroscopy under general anesthesia.

The main questions it aims to answer are:

  1. Does intraoperative dexmedetomidine infusion (0.5 μg/kg/h) improve postoperative sleep quality as measured by the Pittsburgh Sleep Quality Index (PSQI) at 24 h and 48 h after surgery?
  2. Is there an interaction between the type of nerve block (FNB vs. ACB) and the use of dexmedetomidine on postoperative sleep quality?
02

Conditions studied

  • Knee Arthroscopic Surgery
03

In context

Lead sponsor

Affiliated Hospital of Nantong University is the lead sponsor of 97 studies on the registry; 57 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Age 18 to 85 years.
  2. (ASA) physical status I to III.
  3. (BMI) between 18 and 30 kg/m² and body weight > 50 kg.
  4. Scheduled for elective knee arthroscopy under general anesthesia.
  5. Complete preoperative workup, confirmed diagnosis, and indication for knee arthroscopy with complete postoperative medical records.
  6. Normal mental and cognitive status.
  7. Patient or legally authorized representative has provided written for anesthesia and study participation.

Exclusion criteria

Exclusion Criteria:

  1. Refusal to participate in the study.
  2. Inability to communicate effectively.
  3. Known allergy or to any study drug (ropivacaine, dexmedetomidine, propofol, sufentanil, remifentanil, vecuronium, or sevoflurane).
  4. History of knee trauma or knee surgery; diagnosed with immune system disorders (e.g., rheumatoid arthritis, systemic lupus erythematosus); neuromuscular diseases or psychiatric disorders; restless legs syndrome (RLS); periodic limb movement disorder (PLMD).
  5. Coagulation disorders or local infection at the puncture site precluding peripheral nerve block.
  6. Severe hepatic or renal dysfunction.
  7. Severe cardiopulmonary insufficiency.
  8. Pregnancy.
  9. Diagnosis of obstructive sleep apnea (OSA) or requirement for continuous positive airway pressure (CPAP) therapy.
  10. Regular use of sedative-hypnotic drugs (benzodiazepines, non-benzodiazepine hypnotics, melatonin receptor agonists, etc.) or antidepressants/anxiolytics known to affect sleep architecture (e.g., trazodone, mirtazapine) within the past 1 month.
  11. Pittsburgh Sleep Quality Index (PSQI) score > 5.
Terms in these criteria, in plain language(4)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Factorial assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
136 participants (estimated)

Study arms

  • Experimental
    FNB + Placebo

    Femoral nerve block (FNB) with 20mL of 0.375% ropivacaine, combined with intraoperative continuous infusion of normal saline at 0.5 μg/(kg·h) as placebo.

    Drug: ropivacaine (local infiltration) · Drug: Normal saline placebo · Procedure: Femoral Nerve Block

  • Experimental
    FNB + Dexmedetomidine

    Femoral nerve block (FNB) with 20mL of 0.375% ropivacaine, combined with intraoperative continuous infusion of dexmedetomidine at 0.5 μg/(kg·h).

    Drug: ropivacaine (local infiltration) · Drug: Dexmedetomidine · Procedure: Femoral Nerve Block

  • Experimental
    ACB + Placebo

    Adductor canal block (ACB) with 20mL of 0.375% ropivacaine, combined with intraoperative continuous infusion of normal saline at 0.5 μg/(kg·h) as placebo.

    Drug: ropivacaine (local infiltration) · Drug: Normal saline placebo · Procedure: Adductor canal block

  • Experimental
    ACB + Dexmedetomidine

    Adductor canal block (ACB) with 20mL of 0.375% ropivacaine, combined with intraoperative continuous infusion of dexmedetomidine at 0.5 μg/(kg·h).

    Drug: ropivacaine (local infiltration) · Drug: Dexmedetomidine · Procedure: Adductor canal block

Interventions

  • 0.375% ropivacaine solution, 20 mL, administered as a single-shot peripheral nerve block prior to anesthesia induction.

  • 0.5 μg/(kg·h) continuous intravenous infusion, initiated after anesthesia induction and discontinued 30 minutes before the end of surgery.

  • DrugNormal saline placebo

    0.9% normal saline solution, administered as a continuous intravenous infusion at a volume rate matching the dexmedetomidine group (0.5 μg/kg/h equivalent), started after induction and stopped 30 minutes before surgery end.

  • ProcedureFemoral Nerve Block

    Ultrasound-guided femoral nerve block performed at the inguinal region (approximately 2 cm distal to the inguinal ligament) using an in-plane technique. A total of 20 mL of 0.375% ropivacaine is injected 1-2 mm anterior to the femoral nerve.

  • ProcedureAdductor canal block

    Ultrasound-guided adductor canal block performed via the distal approach at the mid-to-lower third of the medial thigh, targeting the adductor hiatus. A total of 20 mL of 0.375% ropivacaine is injected.

06

What researchers measure

Primary outcomes

  1. Pittsburgh Sleep Quality Index (PSQI) scores at 24 hours after surgery

    Sleep quality at 24 hours after surgery will be assessed using the Pittsburgh Sleep Quality Index. The unit of measure is points on a scale. The Pittsburgh Sleep Quality Index includes 7 component scores: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleep medication, and daytime dysfunction. Each component score ranges from 0 to 3. The global Pittsburgh Sleep Quality Index score is calculated as the sum of the 7 component scores, resulting in a total score ranging from 0 to 21. Higher scores indicate poorer sleep quality.

    Time frame: 24 hours post-surgery

Secondary outcomes

  1. Pittsburgh Sleep Quality Index (PSQI) scores at 48 hours after surgery

    Sleep quality at 48 hours after surgery will be assessed using the Pittsburgh Sleep Quality Index. The unit of measure is points on a scale. The Pittsburgh Sleep Quality Index includes 7 component scores: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleep medication, and daytime dysfunction. Each component score ranges from 0 to 3. The global Pittsburgh Sleep Quality Index score is calculated as the sum of the 7 component scores, resulting in a total score ranging from 0 to 21. Higher scores indicate poorer sleep quality.

    Time frame: 48 hours after surgery

  2. Richards-Campbell Sleep Questionnaire (RCSQ) Score at 24 Hours After Surgery

    Subjective sleep quality at 24 hours after surgery will be assessed using the Richards-Campbell Sleep Questionnaire. The unit of measure is points on a scale. The questionnaire includes 5 items assessing sleep depth, sleep latency, number of awakenings, time spent awake, and overall sleep quality. Each item is scored from 0 to 100. The final Richards-Campbell Sleep Questionnaire score is calculated as the mean of the 5 item scores. The final score ranges from 0 to 100, with higher scores indicating better sleep quality.

    Time frame: 24 hours after surgery

  3. Richards-Campbell Sleep Questionnaire (RCSQ) Score at 48 Hours After Surgery

    Subjective sleep quality at 48 hours after surgery will be assessed using the Richards-Campbell Sleep Questionnaire. The unit of measure is points on a scale. The questionnaire includes 5 items assessing sleep depth, sleep latency, number of awakenings, time spent awake, and overall sleep quality. Each item is scored from 0 to 100. The final Richards-Campbell Sleep Questionnaire score is calculated as the mean of the 5 item scores. The final score ranges from 0 to 100, with higher scores indicating better sleep quality.

    Time frame: 48 hours post-surgery

  4. Resting Pain Numeric Rating Scale Score at 6 Hours After Surgery

    Resting pain intensity will be assessed using an 11-point Numeric Rating Scale. The score ranges from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain. Higher scores indicate more severe pain.

    Time frame: 6 hours after surgery

  5. Resting Pain Numeric Rating Scale Score at 24 Hours After Surgery

    Resting pain intensity will be assessed using an 11-point Numeric Rating Scale. The score ranges from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain. Higher scores indicate more severe pain.

    Time frame: 24 hours after surgery

  6. Resting Pain Numeric Rating Scale Score at 48 Hours After Surgery

    Resting pain intensity will be assessed using an 11-point Numeric Rating Scale. The score ranges from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain. Higher scores indicate more severe pain.

    Time frame: 48 hours after surgery

  7. Movement Pain Numeric Rating Scale Score at 6 Hours After Surgery

    Movement pain intensity will be assessed using an 11-point Numeric Rating Scale. The score ranges from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain. Higher scores indicate more severe pain.

    Time frame: 6 hours after surgery

  8. Movement Pain Numeric Rating Scale Score at 24 Hours After Surgery

    Movement pain intensity will be assessed using an 11-point Numeric Rating Scale. The score ranges from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain. Higher scores indicate more severe pain.

    Time frame: 24 hours after surgery

  9. Movement Pain Numeric Rating Scale Score at 48 Hours After Surgery

    Movement pain intensity will be assessed using an 11-point Numeric Rating Scale. The score ranges from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain. Higher scores indicate more severe pain.

    Time frame: 48 hours after surgery

  10. Total Sufentanil Consumption

    Total sufentanil consumption delivered through patient-controlled intravenous analgesia will be recorded in micrograms. Higher consumption indicates greater postoperative opioid requirement.

    Time frame: 0 to 24 hours

  11. Quality of Recovery-15 (QoR-15) score at 24 Hours After Surgery

    Postoperative recovery quality will be assessed using the 15-item Quality of Recovery questionnaire. The total score ranges from 0 to 150, with higher scores indicating better recovery quality.

    Time frame: 24 hours after surgery

  12. Quality of Recovery-15 (QoR-15) score at 48 Hours After Surgery

    Postoperative recovery quality will be assessed using the 15-item Quality of Recovery questionnaire. The total score ranges from 0 to 150, with higher scores indicating better recovery quality.

    Time frame: 48 hours after surgery

  13. Modified Bromage score at 6 Hours After Surgery

    Motor block will be assessed using the modified Bromage score. The score ranges from 0 to 3, where 0 indicates no motor block and 3 indicates complete motor block. Higher scores indicate greater motor impairment.

    Time frame: 6 hours after surgery

  14. Modified Bromage score at 24 Hours After Surgery

    Motor block will be assessed using the modified Bromage score. The score ranges from 0 to 3, where 0 indicates no motor block and 3 indicates complete motor block. Higher scores indicate greater motor impairment.

    Time frame: 24 hours after surgery

  15. Quadriceps Muscle Strength Score at 6 Hours After Surgery

    Quadriceps muscle strength will be assessed using the Medical Research Council muscle strength scale. The score ranges from 0 to 5, where 0 indicates no visible muscle contraction and 5 indicates normal muscle strength. Higher scores indicate better quadriceps muscle strength.

    Time frame: 6 hours after surgery

  16. Quadriceps Muscle Strength Score at 24 Hours After Surgery

    Quadriceps muscle strength at 24 hours after surgery will be assessed using the Medical Research Council muscle strength scale. The unit of measure is points on a scale. Scores range from 0 to 5, where 0 indicates no visible muscle contraction and 5 indicates normal muscle strength. Higher scores indicate better quadriceps muscle strength.

    Time frame: 24 hours after surgery

  17. Quadriceps Muscle Strength Score at 48 Hours After Surgery

    Quadriceps muscle strength at 48 hours after surgery will be assessed using the Medical Research Council muscle strength scale. The unit of measure is points on a scale. Scores range from 0 to 5, where 0 indicates no visible muscle contraction and 5 indicates normal muscle strength. Higher scores indicate better quadriceps muscle strength.

    Time frame: 48 hours after surgery

  18. Time to First Assisted Ambulation

    Time to first assisted ambulation is defined as the time from the end of surgery to the first successful assisted ambulation, including sitting up, standing, and walking with assistance. The time will be recorded in hours. A longer time indicates delayed early mobilization.

    Time frame: From the end of surgery to first assisted ambulation, assessed up to 48 hours after surgery

  19. Mini-Mental State Examination (MMSE) score

    Cognitive function will be assessed using the Mini-Mental State Examination. The total score ranges from 0 to 30, with higher scores indicating better cognitive function.

    Time frame: Baseline and 24 hours after surgery

  20. Incidence of Postoperative Nausea and Vomiting

    The incidence of postoperative nausea and vomiting will be defined as the proportion of participants who experience nausea or vomiting during the first 48 hours after surgery.

    Time frame: 0 to 48 hours after surgery

  21. Proportion of Participants Requiring Rescue Analgesia

    The outcome will be calculated as the proportion of participants who require at least one dose of rescue analgesic medication because the pain score remains greater than 4 despite patient-controlled analgesia. The proportion will be calculated as the number of participants requiring rescue analgesia divided by the total number of participants in each group and expressed as a percentage. A higher percentage indicates a greater requirement for additional analgesia.

    Time frame: From the end of surgery through 48 hours after surgery

  22. Incidence of Perioperative Adverse Events

    Perioperative adverse events will include bradycardia, hypotension, respiratory depression, serious arrhythmia, excessive sedation, local anesthetic systemic toxicity, and other clinically significant adverse events. The outcome will be reported as the proportion of participants experiencing at least one predefined adverse event.

    Time frame: From the start of anesthesia to 48 hours after surgery

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jan 2026 (actual). Primary completion is estimated for Sep 2026, 8 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 19, 2026
First posted
Aug 17, 2026
StartActual
Jan 15, 2026
Primary completionEst.
Sep 30, 2026
CompletionEst.
Dec 31, 2026
Last update
Aug 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 17, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07767383
Lead sponsor
Affiliated Hospital of Nantong University
Responsible party
Sponsor
First posted
Aug 17, 2026
Start date
Jan 15, 2026
Primary completion
Sep 30, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Aug 17, 2026

Study contacts

Ma XQ Ma Xia Qing, doctorate
Contact
lvy_Ma@ntu.edu.cn
0086-18118660387

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Dexmedetomidine

Start the discussion